imipramine and sertraline

imipramine has been researched along with sertraline in 95 studies

Research

Studies (95)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (4.21)	18.7374
1990's	35 (36.84)	18.2507
2000's	32 (33.68)	29.6817
2010's	18 (18.95)	24.3611
2020's	6 (6.32)	2.80

Authors

Authors	Studies
Costanzo, MJ; Gardocki, JF; Maryanoff, BE; McComsey, DF; Nortey, SO; Schneider, CR; Setler, PE; Shank, RP	1
Koe, BK; Kraska, AR; Sarges, R; Welch, WM	1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Buck, LB; Petrascheck, M; Ye, X	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Glen, RC; Lowe, R; Mitchell, JB	1
Gozalbes, R; Pineda-Lucena, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Qin, W; Tian, S; Wold, EA; Xu, Q; Ye, N; Zhen, XC; Zhou, J	1
Alonso, C; Campillo, NE; Cuesta-Geijo, MÁ; Delgado, R; Gil, C; Ginex, T; Morales-Tenorio, M; Muñoz-Fontela, C	1
Chen, W; Han, S; Hu, Y; Li, H; Tong, X; Yang, L; Zuo, J	1
Broekkamp, CL; Jenck, F; Van Delft, AM	1
Koe, BK; Lebel, LA; Welch, WM	1
Aronson, CE; Brunswick, DJ; Frazer, A; Kovachich, GB	1
Phillips, OM; Williams, DC; Wood, KM	1
Fawcett, JA; Gelenberg, A; Harrison, W; Hirschfeld, RM; Keller, MB; Klein, D; Kocsis, JH; McCullough, JP; Rush, AJ; Schatzberg, A	1
Duman, RS; Morinobu, S; Nibuya, M	1
Auerbach, SB; Hjorth, S; Lundberg, JF	1
Preskorn, SH	1
Helmeste, DM; Reist, C; Tang, SW; Vu, R	1
Alpert, JE; Fava, M; Maddocks, A; Rosenbaum, JF	1
Anton, RF; Cunningham, T; Lydiard, RB	1
Kupfer, DJ	1
Duman, RS; Nestler, EJ; Nibuya, M	1
Davidson, J; Fava, M; Halbreich, U; Harrison, W; Kocsis, JH; Koran, L; Rosenbaum, J; Thase, ME	1
Berndt, ER; Finkelstein, SN; Greenberg, PE; Keller, MB; Parsley, RA; Russell, JM	1
Davidson, J; Halbreich, U; Hellerstein, DJ; Kocsis, JH; Rosenbaum, J; Shelton, R; Yonkers, K; Zisook, S	1
Daniel, WA; Wójcikowski, J	3
Davidson, J; Halbreich, U; Koran, L; Pearlstein, T; Shelton, RC; Thase, ME; Yonkers, KA	1
Kamijima, K; Kiuchi, Y; Nara, K; Oguchi, K; Tadokoro, C; Yamazaki, Y	1
Fava, M; Nierenberg, AA; Pearlstein, T; Quitkin, FM; Rosenbaum, JF; Stone, A; Zisook, S	1
Agosti, V; Stewart, JW	1
Buni, TM	1
Ahern, D; Ball, SE; Kao, J; Scatina, J	1
Bergstrom, RF; Cerimele, BJ; Goldberg, MJ; Kurtz, DL	1
de Jonghe, F	1
Kamijima, K; Kiuchi, Y; Oguchi, K; Tadokoro, C; Yamazaki, Y	1
Bouwer, C; Stein, DJ	1
Caliskan, M; Kirli, S	1
Fawcett, JA; Gelenberg, AJ; Harrison, WM; Hirschfeld, RM; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Markowitz, JC; McCullough, JP; Miceli, RJ; Rush, AJ; Schatzberg, AF; Thase, ME	1
Davis, SM; Fawcett, JA; Gelenberg, AJ; Harrison, WM; Hirschfeld, RM; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Kornstein, SG; Markowitz, JC; McCullough, JP; Rush, AJ; Russell, JM; Thase, ME	1
Davis, SM; Harrison, WM; Keitner, GI; Keller, MB; Klein, DN; Kornstein, SG; Markowitz, JC; Miller, IW; Rush, AJ; Schatzberg, AF; Schlager, DS; Thase, ME	1
Connolly, MA; Delgado, PL; Fawcett, J; Friedman, RA; Harrison, WM; Hirschfeld, RM; Howland, RH; Koran, LM; Miceli, RJ; Miller, IW; Russell, JM; Thase, ME	1
Meyers, BS	1
Higuchi, T; Kamijima, K; Kanda, Y; Kiuchi, Y; Momose, K; Morinobu, S; Nara, K; Oguchi, K; Yamada, M	1
Baldwin, D; Bourgeois, M; Healy, D; Hirschfeld, RM; Humble, M; Kasper, S; Keller, MB; Möller, HJ; Montenegro, R; Montgomery, SA; Schatzberg, AF; Versiani, M	1
Berndt, ER; Finkelstein, SN; Gelenberg, AJ; Keller, MB; Koran, LM; Kornstein, SG; Miller, IM; Thase, ME; Trapp, GA	1
Ferreira, RC; Forlenza, OV; Hirata, ES; Stoppe Júnior, A	1
Arancio, C; Bellodi, L; Bertani, A; Caldirola, D; Perna, G	1
Chapman, D; Harrison, W; Hellerstein, DJ; Kocsis, JH; Stewart, JW	1
Davis, SM; Gelenberg, AJ; Harrison, WM; Keitner, GI; Keller, MB; Kornstein, SG; McCullough, JP; Schatzberg, AF; Thase, ME; Yonkers, KA	1
Marsland, TW; Newton, W	1
Davis, S; Friedman, ES; Harrison, W; Hirschfeld, RM; Keller, M; Koran, LM; Rush, J; Russell, JM	1
Higuchi, T; Kamijima, K; Kiuchi, Y; Momose, K; Nara, K; Oguchi, K; Ozawa, H; Takahashi, K; Yamada, M; Yamada, S; Yamazaki, S	1
Almeida, OP; Forlenza, OV; Hirata, ES; Stoppe, A	1
DeBattista, C; Friedman, RA; Gelenberg, AJ; Hirschfeld, RM; Howland, RH; Keller, MB; Klein, D; Kocsis, JH; Koran, LM; Kornstein, SG; LaVange, LM; Rush, AJ; Schatzberg, AF; Thase, ME	1
McGrath, PJ; Quitkin, FM; Stewart, JW	1
Reich, J	1
Fawcett, J; Gelenberg, AJ; Harrison, W; Hirschfeld, RM; Howland, RH; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Kornstein, SG; LaVange, LM; Rush, AJ; Russell, JM; Schatzberg, AF; Thase, ME	1
Blanco, C; Garcia-Toro, M; Gonzalez, A; Gonzalez, E; Saiz-Ruiz, J; Talavera, JA; Tejada, P	1
Baca, E; García-Toro, M; González de Chávez, M; Pérez-Arnau, F; Porras-Chavarino, A	1
Harrison, WM; Hirschfeld, RM; Keller, MB; Kornstein, SG; McCullough, JP; Russell, JM; Shea, MT	1
Abdel-Salam, OM; El-Shenawy, SM; Nofal, SM	1
Arató, M; Austin, C; Lepola, U; Zhu, Y	1
Mavissakalian, MR	2
Baca, E; Garcia-Garcia, M; Porras-Chavarino, A	1
Broadbear, JH; Canny, BJ; Clarke, IJ; Nguyen, T	1
Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G	1
Becker, B; Lebrun, P; Morel, N; Vanbellinghen, AM	1
Arango, V; Cooper, TB; Kent, JM; Mann, JJ; Oquendo, MA; Parsey, RV; Pratap, M; Richards, MC	1
Higuchi, T; Honda, K; Kamijima, K; Kitahara, S; Tanaka, S; Yamada, M	1
Lin, AN; Metelitsa, AI; Nguyen, GK	1
Ros, LT	1
Clary, CM; Harvey, AT; Kornstein, SG; Silkey, BS	1
Lo, V; Maggio, L	1
Kenchaiah, BK; Kumar, S; Tharyan, P	1
Erhart, F; Huemer, J; Steiner, H	1
Frazer, A; Furmaga, H; Shah, A	1
Kitayama, S; Mamiya, T; Miyamoto, Y; Mouri, A; Nabeshima, T; Noda, Y; Sasaki, A; Sogawa, C; Watanabe, K; Yamada, K	1
Cho, HY; Kim, JE; Kim, YH; Lee, BJ; Lee, CH; Lee, JG; Park, SW; Seo, MK; Seol, W	1
Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN	1
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X	1
Imamura, Y; Mouri, A; Murakami, Y; Nabeshima, T; Saito, K; Tashiro, T; Yamamoto, Y	1
Bolding, IJ; Boone, DR; Cardenas, C; DeWitt, DS; Falduto, MT; Hellmich, HL; Micci, MA; Prough, DS; Sell, SL; Torres, KEO; Weisz, HA; Willey, HE	1
Yamini, Y; Zamani, R	1
Deshpande, PS; Fariha, R; Jabrah, M; Okoh, OD; Rothkopf, E; Spooner, A; Tripathi, A	1
Cao, Q; Rao, Y; Yang, R; Zhao, J	1

Reviews

10 review(s) available for imipramine and sertraline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24 Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidines; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries	2020
Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction. European journal of medicinal chemistry, 2021, Nov-05, Volume: 223 Topics: Antibodies; Ebolavirus; Glycoproteins; Hemorrhagic Fever, Ebola; Humans; Molecular Docking Simulation; Niemann-Pick C1 Protein; Protein Binding; Small Molecule Libraries; Virus Internalization	2021
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6 Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride	1995
Management of recurrent depression. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Imipramine; Paroxetine; Psychotherapy; Recurrence; Sertraline	1993
Depression and dementia: comorbidities, identification, and treatment. Journal of geriatric psychiatry and neurology, 1998,Winter, Volume: 11, Issue:4 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline	1998
Social functioning in depression: a review. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:4 Topics: Adaptation, Psychological; Antidepressive Agents; Clinical Trials as Topic; Cost of Illness; Depressive Disorder; Health Status; Humans; Imipramine; Psychiatric Status Rating Scales; Psychotherapy; Quality of Life; Research Design; Sertraline; Social Adjustment; Treatment Outcome	2000
Posttraumatic stress disorder in children and adolescents: a review of psychopharmacological treatment. Child psychiatry and human development, 2010, Volume: 41, Issue:6 Topics: Adolescent; Antidepressive Agents; Child; Humans; Imipramine; Randomized Controlled Trials as Topic; Sertraline; Stress Disorders, Post-Traumatic; Valproic Acid	2010
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London, England), 2016, Aug-27, Volume: 388, Issue:10047 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride	2016
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2022, Aug-01, Volume: 51, Issue:4 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride	2022

Trials

33 trial(s) available for imipramine and sertraline

Article	Year
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacology bulletin, 1995, Volume: 31, Issue:2 Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Chronic Disease; Depression; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1995
Childhood psychopathology retrospectively assessed among adults with early onset major depression. Journal of affective disorders, 1994, Volume: 31, Issue:3 Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Paroxetine; Personality Development; Phobic Disorders; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	1994
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Archives of general psychiatry, 1996, Volume: 53, Issue:9 Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Chronic Disease; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1996
Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group. Psychopharmacology bulletin, 1996, Volume: 32, Issue:1 Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Depressive Disorder; Humans; Imipramine; Psychiatric Status Rating Scales; Sertraline; Task Performance and Analysis	1996
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. The American journal of psychiatry, 1997, Volume: 154, Issue:3 Topics: 1-Naphthylamine; Adult; Age of Onset; Aged; Antidepressive Agents; Double-Blind Method; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Placebos; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Social Adjustment; Treatment Outcome	1997
The undertreatment of dysthymia. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:2 Topics: 1-Naphthylamine; Adult; Age of Onset; Aged; Ambulatory Care; Antidepressive Agents; Comorbidity; Dysthymic Disorder; Family; Female; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Personality Disorders; Placebos; Prevalence; Psychiatric Status Rating Scales; Psychotherapy; Sertraline; Single-Blind Method; Treatment Outcome	1997
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia. Psychopharmacology bulletin, 1997, Volume: 33, Issue:1 Topics: 1-Naphthylamine; Adult; Aged; Anger; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline	1997
Six month follow-up of early-onset chronic depression. Depression, 1996, Volume: 4, Issue:2 Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Discharge; Prognosis; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1996
Treatment of dysthymia. The Journal of family practice, 1997, Volume: 44, Issue:6 Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1997
The effect of sertraline on the pharmacokinetics of desipramine and imipramine. Clinical pharmacology and therapeutics, 1997, Volume: 62, Issue:2 Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Desipramine; Half-Life; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline	1997
A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia. Schizophrenia research, 1998, Sep-07, Volume: 33, Issue:1-2 Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline	1998
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:11 Topics: Antidepressive Agents, Tricyclic; Chronic Disease; Clinical Protocols; Comorbidity; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Dysthymic Disorder; Follow-Up Studies; Humans; Imipramine; Patient Dropouts; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1998
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:11 Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Patient Selection; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1998
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:11 Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Follow-Up Studies; Health Status; Humans; Imipramine; Male; Middle Aged; Personal Satisfaction; Personality Inventory; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Adjustment; Surveys and Questionnaires; Treatment Outcome	1998
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:12 Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Educational Status; Female; Humans; Imipramine; Male; Middle Aged; Personality; Probability; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Social Adjustment; Treatment Outcome	1998
Lost human capital from early-onset chronic depression. The American journal of psychiatry, 2000, Volume: 157, Issue:6 Topics: Adult; Age of Onset; Aged; Censuses; Chronic Disease; Cost of Illness; Depressive Disorder; Double-Blind Method; Educational Status; Female; Humans; Imipramine; Income; Male; Middle Aged; Outcome Assessment, Health Care; Regression Analysis; Sertraline; Sex Factors; Treatment Outcome; United States	2000
Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients. Sao Paulo medical journal = Revista paulista de medicina, 2000, Jul-06, Volume: 118, Issue:4 Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Double-Blind Method; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome	2000
Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:2 Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Carbon Dioxide; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Multivariate Analysis; Panic Disorder; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline	1997
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality. The American journal of psychiatry, 2000, Volume: 157, Issue:9 Topics: Adult; Age of Onset; Antidepressive Agents, Tricyclic; Double-Blind Method; Dysthymic Disorder; Factor Analysis, Statistical; Female; Humans; Imipramine; Male; Personality; Personality Inventory; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Adjustment; Temperament; Treatment Outcome	2000
Gender differences in treatment response to sertraline versus imipramine in chronic depression. The American journal of psychiatry, 2000, Volume: 157, Issue:9 Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Estrogens; Female; Humans; Imipramine; Male; Middle Aged; Patient Dropouts; Placebos; Premenopause; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sex Factors; Treatment Outcome	2000
Are there differences by gender in response to pharmacotherapy for depression? The Journal of family practice, 2000, Volume: 49, Issue:12 Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Confounding Factors, Epidemiologic; Depressive Disorder; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome	2000
Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depression and anxiety, 2001, Volume: 13, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Analysis of Variance; Anxiety Disorders; Chronic Disease; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2001
Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial. International psychogeriatrics, 2001, Volume: 13, Issue:1 Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brazil; Cost-Benefit Analysis; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Male; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Therapeutic Equivalency; Treatment Outcome	2001
Sertraline versus imipramine to prevent relapse in chronic depression. Journal of affective disorders, 2001, Volume: 65, Issue:1 Topics: Adult; Aged; Chronic Disease; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Sertraline	2001
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Archives of general psychiatry, 2002, Volume: 59, Issue:3 Topics: Adult; Cross-Over Studies; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Prospective Studies; Sertraline; Treatment Outcome	2002
Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicentre, randomized study. Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:3 Topics: Adolescent; Adult; Aged; Analysis of Variance; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Sertraline	2003
Chronic depression and comorbid personality disorders: response to sertraline versus imipramine. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:5 Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Personality Disorders; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Survival Analysis; Treatment Outcome	2003
Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:6 Topics: Adult; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2003
Sertraline in panic disorder: initial treatment versus switch strategy. Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:6 Topics: Adrenergic Uptake Inhibitors; Adult; Cohort Studies; Female; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Retreatment; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure	2003
Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:1 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Imipramine; Male; Patient Acceptance of Health Care; Psychiatric Status Rating Scales; Sertraline; Sex Characteristics; Socioeconomic Factors	2004
Switching from imipramine to sertraline in panic disorder. Journal of psychiatric practice, 2004, Volume: 10, Issue:2 Topics: Adult; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method	2004
Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography. Biological psychiatry, 2006, May-01, Volume: 59, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Aged; Autoradiography; Benzylamines; Brain; Brain Mapping; Carbon Isotopes; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Image Processing, Computer-Assisted; Imipramine; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Postmortem Changes; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Time Factors; Tissue Distribution; Tritium	2006
Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:6 Topics: Adult; Cross-Over Studies; Depressive Disorder, Major; Disease Progression; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Menopause; Middle Aged; Patient Dropouts; Sertraline; Sex Factors; Treatment Outcome	2007

Other Studies

52 other study(ies) available for imipramine and sertraline

Article	Year
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships. Journal of medicinal chemistry, 1987, Volume: 30, Issue:8 Topics: Animals; Antidepressive Agents; Blepharoptosis; Brain; Catecholamines; Chemical Phenomena; Chemistry; Dopamine; Isoquinolines; Male; Molecular Conformation; Motor Activity; Norepinephrine; Pyrroles; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Structure-Activity Relationship; Synaptosomes; Tetrabenazine	1987
Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins. Journal of medicinal chemistry, 1984, Volume: 27, Issue:11 Topics: Animals; Antidepressive Agents; Dopamine; Isomerism; Male; Naphthalenes; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism; Synaptosomes; Tetrahydronaphthalenes; X-Ray Diffraction	1984
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature, 2007, Nov-22, Volume: 450, Issue:7169 Topics: Aging; Animals; Antidepressive Agents; Caenorhabditis elegans; Caloric Restriction; Humans; Longevity; Methiothepin; Mianserin; Octopamine; Receptors, Biogenic Amine; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; Starvation	2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
QSAR-based solubility model for drug-like compounds. Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19 Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1 Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity	2013
Discovery of potent ebola entry inhibitors with (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold. European journal of medicinal chemistry, 2022, Oct-05, Volume: 240 Topics: Antiviral Agents; Ebolavirus; Hemorrhagic Fever, Ebola; HIV Fusion Inhibitors; Humans; Molecular Docking Simulation; Virus Internalization	2022
The effect of antidepressants on aversive periaqueductal gray stimulation in rats. European journal of pharmacology, 1990, Feb-27, Volume: 177, Issue:3 Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Biogenic Monoamines; Dopamine; Dose-Response Relationship, Drug; Electric Stimulation; Fluvoxamine; Imipramine; Male; Nomifensine; Norepinephrine; Oximes; Periaqueductal Gray; Rats; Rats, Inbred Strains; Reinforcement, Psychology; Serotonin; Sertraline	1990
[3H] sertraline binding to rat brain membranes. Psychopharmacology, 1990, Volume: 100, Issue:4 Topics: 1-Naphthylamine; Animals; Brain; Fenclonine; Fluoxetine; Imipramine; In Vitro Techniques; Male; Membranes; Naphthalenes; Paroxetine; Piperidines; Rats; Receptors, Serotonin; Serotonin Antagonists; Sertraline	1990
Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine. Brain research, 1988, Jun-28, Volume: 454, Issue:1-2 Topics: 1-Naphthylamine; Animals; Autoradiography; Binding, Competitive; Brain; Fluoxetine; Imipramine; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sertraline; Zimeldine	1988
Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier. European journal of pharmacology, 1988, Feb-09, Volume: 146, Issue:2-3 Topics: 1-Naphthylamine; Alanine; Binding, Competitive; Blood Platelets; Cell Membrane; Humans; Imipramine; In Vitro Techniques; Naphthalenes; Receptors, Serotonin; Serotonin; Sertraline	1988
Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1995, Volume: 12, Issue:3 Topics: 1-Naphthylamine; Amino Acid Isomerases; Animals; Antidepressive Agents; Carrier Proteins; Desipramine; Down-Regulation; Frontal Lobe; Imipramine; Male; Peptidylprolyl Isomerase; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Restraint, Physical; RNA, Messenger; Sertraline; Stress, Psychological; Time Factors; Tranylcypromine	1995
Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology, 1995, Volume: 34, Issue:1 Topics: 1-Naphthylamine; Animals; Citalopram; Hippocampus; Imipramine; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Time Factors	1995
Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets. European journal of pharmacology, 1995, Feb-15, Volume: 288, Issue:3 Topics: 1-Naphthylamine; Blood Platelets; Calcium; Calmodulin; Cells, Cultured; Fluoxetine; Humans; Imipramine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1995
Interactions between sertraline and tricyclic antidepressants. The American journal of psychiatry, 1993, Volume: 150, Issue:7 Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Drug Interactions; Humans; Imipramine; Male; Selective Serotonin Reuptake Inhibitors; Sertraline	1993
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1996, Apr-01, Volume: 16, Issue:7 Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Base Sequence; Blotting, Northern; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Desipramine; Electric Stimulation; Fluoxetine; Hippocampus; Imipramine; In Situ Hybridization; Male; Molecular Sequence Data; Nerve Growth Factors; Nerve Tissue Proteins; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, trkB; Receptors, Nerve Growth Factor; RNA, Messenger; Rolipram; Sertraline; Time Factors; Tranylcypromine	1996
Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs. Pharmacology & toxicology, 1997, Volume: 80, Issue:2 Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Drug Interactions; Fluoxetine; Imipramine; Lysosomes; Male; Monensin; Phospholipids; Promazine; Psychotropic Drugs; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Distribution	1997
Behavioral stimulation without alteration of beta and 5-HT receptors and adenylate cyclase activity in rat brain after chronic sertraline administration. Psychopharmacology, 1997, Volume: 130, Issue:2 Topics: 1-Naphthylamine; Adenylyl Cyclases; Animals; Behavior, Animal; Binding, Competitive; Brain; Brain Chemistry; Cerebral Cortex; Cyclic AMP; Imipramine; Kinetics; Male; Neurotransmitter Uptake Inhibitors; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline	1997
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2. British journal of clinical pharmacology, 1997, Volume: 43, Issue:6 Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride	1997
Sertraline and imipramine for the treatment of dysthymia. Archives of general psychiatry, 1997, Volume: 54, Issue:10 Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Dysthymic Disorder; Humans; Imipramine; Placebos; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline	1997
Interactions between promazine and antidepressants at the level of cellular distribution. Pharmacology & toxicology, 1997, Volume: 81, Issue:6 Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Fluoxetine; Hydrogen-Ion Concentration; Imipramine; Lysosomes; Male; Promazine; Rats; Rats, Wistar; Sertraline	1997
Effects of imipramine and sertraline on protein kinase activity in rat frontal cortex. European journal of pharmacology, 1998, Jan-19, Volume: 342, Issue:1 Topics: 1-Naphthylamine; Animals; Antidepressive Agents, Tricyclic; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cyclic AMP-Dependent Protein Kinases; Hippocampus; Imipramine; Male; Parietal Lobe; Prefrontal Cortex; Protein Kinase C; Protein Kinases; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Temporal Lobe	1998
Survivors of torture presenting at an anxiety disorders clinic: symptomatology and pharmacotherapy. The Journal of nervous and mental disease, 1998, Volume: 186, Issue:5 Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Female; Humans; Imipramine; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; South Africa; Survivors; Torture; Treatment Outcome	1998
The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions. Toxicology and applied pharmacology, 1999, Jul-15, Volume: 158, Issue:2 Topics: Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents; Chromatography, High Pressure Liquid; Drug Interactions; Fluoxetine; Imipramine; In Vitro Techniques; Lysosomes; Male; Monensin; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Thioridazine	1999
Identification of a novel splice variant of heat shock cognate protein 70 after chronic antidepressant treatment in rat frontal cortex. Biochemical and biophysical research communications, 1999, Aug-02, Volume: 261, Issue:2 Topics: Alternative Splicing; Amino Acid Sequence; Animals; Antidepressive Agents; Base Sequence; Carrier Proteins; Cerebral Cortex; DNA Primers; DNA, Complementary; Exons; Genetic Variation; HSC70 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Imipramine; Male; Molecular Sequence Data; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sertraline	1999
Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex. Neuroscience letters, 2001, Apr-06, Volume: 301, Issue:3 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; DNA, Complementary; Frontal Lobe; Gene Expression Regulation; HSP40 Heat-Shock Proteins; Imipramine; Male; Membrane Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sertraline	2001
Gender differences in treatment response. The American journal of psychiatry, 2001, Volume: 158, Issue:9 Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Menopause; Numerical Analysis, Computer-Assisted; Patient Dropouts; Proportional Hazards Models; Regression Analysis; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Survival Analysis; Treatment Outcome	2001
Personality change after treatment. The American journal of psychiatry, 2002, Volume: 159, Issue:1 Topics: Double-Blind Method; Dysthymic Disorder; Humans; Imipramine; Personality Assessment; Personality Disorders; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome	2002
Audioverbal cognitive dysfunction in depression. Factors involved. Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:1 Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention; Cognition Disorders; Depression; Female; Humans; Imipramine; Male; Memory Disorders; Middle Aged; Reaction Time; Sertraline; Severity of Illness Index; Task Performance and Analysis	2003
Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat. Pharmacological research, 2003, Volume: 48, Issue:2 Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Carrageenan; Clomipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Fluoxetine; Imipramine; Inflammation; Male; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Sertraline; Trazodone	2003
Antidepressants, sex steroids and pituitary-adrenal response in sheep. Psychopharmacology, 2004, Volume: 175, Issue:2 Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Female; Gonadal Steroid Hormones; Hydrocortisone; Imipramine; Male; Orchiectomy; Ovariectomy; Pituitary-Adrenal System; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Characteristics; Sheep	2004
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose? European journal of clinical pharmacology, 2004, Volume: 60, Issue:3 Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride	2004
Blockade of calcium entry in smooth muscle cells by the antidepressant imipramine. Biochemical pharmacology, 2004, Sep-01, Volume: 68, Issue:5 Topics: Animals; Antidepressive Agents; Aorta; Calcium; Calcium Channel Blockers; Calcium Channels; Colon; Drug Combinations; Female; Imipramine; Mianserin; Muscle Contraction; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenylephrine; Potassium Chloride; Rats; Rats, Wistar; Rubidium; Sertraline; Verapamil	2004
Induction of neuroserpin expression in rat frontal cortex after chronic antidepressant treatment and electroconvulsive treatment. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2006, Volume: 26, Issue:1 Topics: Animals; Antidepressive Agents; Cyclohexanols; Electroconvulsive Therapy; Expressed Sequence Tags; Fluoxetine; Frontal Lobe; Imipramine; Male; Neuropeptides; Neuroserpin; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serpins; Sertraline; Venlafaxine Hydrochloride	2006
Imipramine-induced facial pigmentation: case report and literature review. Journal of cutaneous medicine and surgery, 2005, Volume: 9, Issue:6 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Tricyclic; Depression; Facial Dermatoses; Female; Humans; Hyperpigmentation; Imipramine; Male; Microscopy, Electron; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Skin; Staining and Labeling; Time Factors	2005
Treatment of postpsychotic depression with sertraline in patients with schizophrenia--own experience. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2006, Volume: 8, Issue:3 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Imipramine; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Sertraline; Treatment Outcome	2006
Clinical inquiries. What's best when a patient doesn't respond to the maximum dose of an antidepressant? The Journal of family practice, 2010, Volume: 59, Issue:3 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Cognitive Behavioral Therapy; Depression; Humans; Imipramine; Lithium; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure	2010
Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients. International journal of dermatology, 2010, Volume: 49, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Ectoparasitic Infestations; Female; Fluoxetine; Haloperidol; Humans; Imipramine; Male; Middle Aged; Olanzapine; Pimozide; Retrospective Studies; Risperidone; Schizophrenia, Paranoid; Sertraline	2010
Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats. Biological psychiatry, 2011, Nov-15, Volume: 70, Issue:10 Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Anxiety; Autoradiography; Brain; Desipramine; Disease Models, Animal; Drug Delivery Systems; Exploratory Behavior; Feeding Behavior; Imipramine; Immobility Response, Tonic; Male; Neural Pathways; Norepinephrine; Oxidopamine; Protein Binding; Rats; Rats, Sprague-Dawley; Reaction Time; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists; Sertraline; Swimming; Time Factors; Tritium; Vagus Nerve Stimulation	2011
MAGE-D1 regulates expression of depression-like behavior through serotonin transporter ubiquitylation. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Mar-28, Volume: 32, Issue:13 Topics: Animals; Antidepressive Agents; Antigens, Neoplasm; Behavior, Animal; Brain; CHO Cells; Cricetinae; Depression; Female; Gene Knockdown Techniques; Imipramine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microinjections; Neoplasm Proteins; Protein Binding; RNA, Small Interfering; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Ubiquitination	2012
Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures. Neuropharmacology, 2014, Volume: 79 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cell Enlargement; Cells, Cultured; Citalopram; Dendrites; Fluoxetine; Hippocampus; Imipramine; Nerve Tissue Proteins; Neurons; Paroxetine; Rats; Rats, Sprague-Dawley; Sertraline; Thiazepines; Tranylcypromine	2014
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats. Bulletin of experimental biology and medicine, 2016, Volume: 160, Issue:5 Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride	2016
Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions. Behavioural brain research, 2017, 01-15, Volume: 317 Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Depressive Disorder, Major; Disease Models, Animal; Exploratory Behavior; Food Preferences; Hippocampus; Imipramine; Kynurenine; Kynurenine 3-Monooxygenase; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Sertraline; Sucrose; Swimming; Tryptophan	2017
MicroRNA profiling identifies a novel compound with antidepressant properties. PloS one, 2019, Volume: 14, Issue:8 Topics: Animals; Antidepressive Agents; Brain Injuries, Traumatic; Computational Biology; Depression; Disease Models, Animal; Estradiol; Fluoxetine; Gene Expression Regulation; Hippocampus; Humans; Imipramine; MicroRNAs; Rats; Sertraline; Sulfonamides; Thiazoles	2019
On-Chip Electromembrane Surrounded Solid Phase Microextraction for Determination of Tricyclic Antidepressants from Biological Fluids Using Poly(3,4-ethylenedioxythiophene)-Graphene Oxide Nanocomposite as a Fiber Coating. Biosensors, 2023, Jan-14, Volume: 13, Issue:1 Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Desipramine; Humans; Imipramine; Limit of Detection; Maprotiline; Nanocomposites; Nortriptyline; Reproducibility of Results; Sertraline; Solid Phase Microextraction	2023
An in-depth analysis of four classes of antidepressants quantification from human serum using LC-MS/MS. Scientific reports, 2023, 02-06, Volume: 13, Issue:1 Topics: Antidepressive Agents; Chromatography, Liquid; Female; Humans; Imipramine; Male; Reproducibility of Results; Sertraline; Tandem Mass Spectrometry	2023